Neogen (NEOG) reported dramatically improved financial results for Q2, with the company’s net loss shrinking to $15.9 million ($0.07 per share) from a staggering $456.3 million loss ($2.10 per share) in the same quarter last year. This represents a substantial turnaround in the company’s financial trajectory.
Adjusted Profitability Shows Resilience
When examining adjusted net income, which filters out one-time charges, Neogen posted $22.6 million ($0.10 per share) in Q2, down slightly from $24.4 million ($0.11 per share) year-over-year. The company’s adjusted figures aligned closely with market expectations, as analysts had anticipated earnings of $0.07 per share before accounting for special items.
Revenue Performance Mixed But Core Business Strengthens
Total revenues declined 2.8% to $224.7 million versus $231.3 million in the prior-year quarter. However, the company’s core revenue segment painted a more optimistic picture, growing by 2.9%, indicating underlying business momentum despite top-line headwinds.
Full-Year Outlook Gets Boost
Looking ahead to fiscal year 2026, Neogen is raising its forward guidance. The company now anticipates revenues between $845 million and $855 million, with adjusted EBITDA projected at approximately $175 million. This upgraded outlook signals management confidence in the company’s strategic direction.
Stock Market Responds Positively
The market rewarded the improved operational trajectory. In pre-market trading on NasdaqGS, Neogen shares surged 19.4% to $8.81, reflecting investor optimism about the company’s recovery path and future prospects.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Neogen Narrows Losses Significantly, Raises 2026 Guidance Amid Market Shift
Neogen (NEOG) reported dramatically improved financial results for Q2, with the company’s net loss shrinking to $15.9 million ($0.07 per share) from a staggering $456.3 million loss ($2.10 per share) in the same quarter last year. This represents a substantial turnaround in the company’s financial trajectory.
Adjusted Profitability Shows Resilience
When examining adjusted net income, which filters out one-time charges, Neogen posted $22.6 million ($0.10 per share) in Q2, down slightly from $24.4 million ($0.11 per share) year-over-year. The company’s adjusted figures aligned closely with market expectations, as analysts had anticipated earnings of $0.07 per share before accounting for special items.
Revenue Performance Mixed But Core Business Strengthens
Total revenues declined 2.8% to $224.7 million versus $231.3 million in the prior-year quarter. However, the company’s core revenue segment painted a more optimistic picture, growing by 2.9%, indicating underlying business momentum despite top-line headwinds.
Full-Year Outlook Gets Boost
Looking ahead to fiscal year 2026, Neogen is raising its forward guidance. The company now anticipates revenues between $845 million and $855 million, with adjusted EBITDA projected at approximately $175 million. This upgraded outlook signals management confidence in the company’s strategic direction.
Stock Market Responds Positively
The market rewarded the improved operational trajectory. In pre-market trading on NasdaqGS, Neogen shares surged 19.4% to $8.81, reflecting investor optimism about the company’s recovery path and future prospects.